Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
According to my phone call with TDA.
The Press Releases stating the "completed its due diligence in connection with the acquisition of" is equal to the contractual agreements. An associate that uses E Trade called yesterday and was told the same thing. If that is in fact true, we may be looking at actual filings next. For what it's worth...
Microcap Daily The Inside Scoop on GRN Holding Corp (OTCMKTS: GRNF)
https://microcapdaily.com/the-inside-scoop-on-grn-holding-corp-otcmkts-grnf/124882/
HealthLynked Corp Steps Up March Toward Profitability
https://finance.yahoo.com/news/healthlynked-corp-steps-march-toward-130800916.html?.tsrc=fin-srch
Stockholders' equity:
Common stock, par value $0.001, 282,985,560 and 273,761,955
shares issued and outstanding at December 31, 2019 and
June 30, 2019; 900,000,000 shares authorized
Re-Posted article with the Predictive mentioned in bold It's a soft mention, however any mention is good.
New York, Feb. 05, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global fertility testing market was valued at 403.7 million in 2018 and is expected to reach USD 702.3 million by the year 2026, at a CAGR of 7.1%. Fertility testing market is rising due to delay in pregnancy, and due to the late pregnancy cases, as after crossing the age of 30, female decreases the chance of conceiving and further till the age of 35, the chance of conceiving further declines. Due to this, there is a fewer number of eggs left in the ovaries, which leads to irregular or absence of a menstrual cycle, PCOS & POI further proceeds for infertility. Damaged sperm is the most common cause of male infertility. The factors driving the industry includes the rise in PCOS disorders, increasing primary ovarian insufficiency (POI) and low sperm motility.
Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/2510
Fertility kits are developed to check fertility in which mostly the ovulation test kits are used, for detecting luteinizing hormone (LH) level and sometimes even estrogen levels to predict the ovulation. These kits, however, do not provide exact information about ovulation. The luteinized unruptured follicle syndrome ovulation predictor fails to give proper results. Also, LH measurement predicts ovulation and cannot determine the date of ovulation or anovulation. The leading manufacturers in the industry are Clearblue (Swiss Precision Diagnostics GmbH), First Response, and Prestige. With the rise in importance of testing and development of ovulation monitors, a decline in the fertility rate globally among females, and easily accessible ovulation monitors are few other factors contributing to the market growth. As ovulation monitors are expensive and do not precisely confirm ovulation, these factors act as a restraint to the market.
Further key findings from the report suggest
Fertility testing market will be expanding with the increase in the number of equipment with digitalized testing, and modern fertility testing that provides data associated to hormone levels. It tracks fertility markers over a period and, creates an individualized fertility curve that gives women more information about their ovarian eggs and details about menopause.
Telehealth solutions are a boom to the fertility testing market, the testing is done using an ovulation kit, and further, the consulting can be done through a camera video, etc.
In the year 2018, Predictive Technology Group, Inc. had launched endometriosis risk test ARTguide. It is a noninvasive diagnostic test and was associated with detecting various genetic and endometriosis which was further leading to infertility.
In July 2018, Merck KGaA had launched (Fertility.com), which enabled healthcare professionals and doctors to access the latest researches and scientific information and was also a help to those who were undergoing fertility treatment, this positioned Merck to be the market leader.
Microbiome modulation has made advances to treat infertility. The Co-founders of Microgenesis have created an infertility diagnosis and treatment for the complicated issues associated with fertility. That is mostly due to immunological problems. Preventive treatment includes the biomedical diet, which contains amino acids, minerals, probiotics, and vitamins.
Sperm count kits have also been discovered, for instance, YO Sperm Test is an home testing kit which allows to check and analyze the sperm count and motility and also visualizes the sperm in the form of the video.
Obese women are likely to suffer from infertility. Even after getting pregnant there are chances of miscarriages, fetal death, and premature delivery and due to this reason the IVI technique is used so that it will improve the chances for fertilization.
IVM (In Vitro Maturation) is a procedure where immature eggs from a woman are allowed to grow in a lab, and after the eggs are mature, they’re fertilized and implanted. This process has the potential to help women with certain gynecological disorders to have children.
Advacare Pharma (U.S.), AVA, Babystart (UK), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (U.S.), Sensiia (UK), Taidoc, Medical Uebe (Germany), Valley Electronics (Switzerland) are the key players in the market.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/fertility-testing-market
Segments covered in the report:
For the purpose of this report, Reports and Data has segmented the fertility testing market on the basis of product, mode of purchase, type, application, distribution channel, end use and region:
Product Outlook (Revenue in Million USD; 2016–2026)
Ovulation test kits
Saliva & Strip Based
Monitor Touch Screen
Fertility monitors
Urine-Based Monitors
Pregnancy Rapid Test
Line Indicators
Strip/Dip Sticks
Mid-Stream Device
Cassettes
Other Fertility Monitors
Basal Body Temperature,
Cervical Mucus,
Perspiration Monitoring
Male Fertility Testing Product
Mode of Purchase Outlook (Revenue in Million USD; 2016–2026)
OTC & Non Prescription
Prescription based
Type Outlook (Revenue in Million USD; 2016–2026)
HCG Blood test
HCG Urine test
FSH Urine test
Application Outlook (Revenue in Million USD; 2016–2026)
Female fertility testing
Male Fertility Testing
Distribution Channel Outlook (Revenue in Million USD; 2016–2026)
Pharmacies
Drugstores
Online Sales
Hypermarkets & Supermarkets
End Use Outlook (Revenue in Million USD; 2016–2026)
Home care
Hospitals, Fertility Clinics,
Others
Order Now: https://www.reportsanddata.com/checkout-form/2510
Regional Outlook (Revenue in USD Million; 2016–2026)
North America
U.S.
Europe
France
UK
Asia Pacific
China
India
Japan
Latin America
Brazil
Middle East and Africa
Browse more similar reports on Diagnostics category by Reports And Data
Photomedicine Market - https://www.reportsanddata.com/report-detail/photomedicine-market
In-Vitro Diagnostics (IVD) Quality Control Market - https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-market
Point of Care (PoC) Diagnostics Market - https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
HealthLynked Corp. Posts Realtime Corona Virus Tracker on Its Website
https://www.marketwatch.com/press-release/healthlynked-corp-posts-realtime-corona-virus-tracker-on-its-website-2020-02-05?mod=mw_quote_news
Nice Find Brian...
Check out the video on Atrin. Having researched cancer myself for personal reasons. I find this to be exciting...
https://www.atrinpharma.com/
https://cancerletter.com/articles/20200131_6/
Adding more credibility....
HLYK News: A National Healthcare Pricing Transparency Tool for Patients
https://finance.yahoo.com/news/healthlynked-corp-releases-cost-lynk-143400108.html
https://www.otcmarkets.com/stock/HLYK/security
News: A National Healthcare Pricing Transparency Tool for Patients
https://finance.yahoo.com/news/healthlynked-corp-releases-cost-lynk-143400108.html
Aaron Freeman - GRNF - Strategic Advisory Board
Real Estate Broker
Ranked in the top 10 at Realogics Sotheby's and top 1% of 30,000 agents in Washington State.
Real Estate Broker
Licensed Texas Realtor buying and selling residential real estate and land; 34 transactions in 21 months; 26 buyers and 8 listings. 100% Club in 2013 and 2014.
Project Controls Engineer, Overseas Buildings Operations (OBO) U.S. Department of State, Islamabad, Pakistan.
New Embassy Compound (NEC) Islamabad & Housing Project, $1 billion – multiple contracts.
Project Manager
Camp Zafar, Herat, Afghanistan
Camp Zafar Utilities Upgrade Project, $7 million. Managed Afghan employees, subcontractors and vendors.
Project Engineer
Valletta, Malta
New Embassy Compound (NEC) in Valletta, Malta, $88 million.
Project Engineer
Khartoum, Sudan
New Embassy Compound (NEC) in Khartoum, Sudan, $172 million.
Project Coordinator
Hyattsville, Maryland
USAID Annex ($8 million) at U.S. Embassy in Kingston, Jamaica.
US Consulate renovation ($12 million) in Hermosillo, Mexico.
Attended/reported pre-solicitation visits in Bern, Switzerland NAB for new U.S. Embassy ($45 million)
Dar es Salaam Cabana/Pool Recreation Center addition ($1.5 million) to existing U.S. Embassy in Dar Es Salaam, Tanzania.
Real Estate Broker
Scottsdale, Arizona
Project Engineer
Sofia, Bulgaria
New Embassy Compound (NEC) in Sofia, Bulgaria $95 million.
Office Engineer
Lima Province, Peru
USAID Annex ($10 million) at the existing U.S. Embassy in Lima, Peru.
Project Engineer
San Jose, California
Project Engineer for TyCom TeleExchange facility, $25 million.
Title Estimator
Charlotte, North Carolina Area
Projects including, but not limited to, the following: New Embassy Compound (NEC) Tunis, Tunisia, Airport in Curacao; U.S. Army Corps of Engineers project in Israel; NEC Yerevan, Armenia; NEC Dar es Salaam, Tanzania; NEC Nairobi, Kenya; NEC Abu Dhabi, United Arab Emirates.
Attention Applicant;
In submitting the following application and documentation, you are filing multiple applications with a single submission.
First of all, you are applying to CannaTrac® Technology, Inc. for acceptance onto the CannaCard®platform. In order to use the CannaCard® platform, you will be required to open and maintain an account with Pacific Banking Corp (PBC). This application and the documents you provide will be released by CannaTrac® to PBC to apply for a Capital Management or Commercial Bank Account.
CannaTrac is not your custodian. The account with PBC will be set up for your company and CannaTrac will not have access to this account at any time without your permission. CannaTrac and PBC are separate legal entities. The concept behind the sharing of information is to create a streamlined application process for the potential CannaCard client; one application equals quicker turn-times and the ability to pass on cost savings to the client through lower required minimums and start rates.
By filling out this application, you are aware that both CannaTrac and PBC charge application fees. A non-refundable fee of $495 will be charged by CannaTrac to process the initial paperwork, complete a due-diligence package, and set up your account on the platform. PBC charges a $2,500 application fee (to be paid directly to them, not through CannaTrac). This allows PBC to follow their own due-diligence process necessary to stay compliant with their “Know Your Customer” policy and Anti-money Laundering / Bank Secrecy Act guidelines.
Fees to use the CannaCard platform are very straightforward. Our retail clients pay 2.45% and $0.50 per transaction. If a client is using an online sales portal, website or e-commerce site, a fee of 2.95% and$0.50 will be charged per transaction. PBC will charge 2% per deposit and require an initial and ongoing minimum of $10,000. This will create an effective rate of 4.45%-4.95% plus $0.50 per transaction.
https://thecannacard.com/static/client/CannaCard_Long_App.pdf
Selected to Rising Stars: 2010, 2014 - 2016
https://profiles.superlawyers.com/washington/seattle/lawyer/aaron-a-pelley/fb8efd42-b8dc-4815-a799-4217c09cefb0.html
https://lawyers.norml.org/washington/aaron-a-pelley-42000507
Aaron A. Pelley, Senior Attorney at Cultiva Law, PLLC. He is a founding member of the Cannabis Defense Coalition, Legal Committee and a Lifetime Member of the Legal Committee for the National Organization on the Reform of Marijuana Laws (NORML). In addition to representing cannabis clients, Mr. Pelley has also earned a reputation for effectively handling high profile cases, representing both individual and corporate clients.
Mr. Pelley has been named a "Rising Star" by Super Lawyers multiple times and has been named Top 100 Trial Lawyers by the National Trial Lawyer College for the last five years. Aaron has been invited to speak about marijuana laws and legal education seminars and conventions throughout the World.
CannaTrac® Announces Agreement with Pacific Banking Corp...
Chicago, IL, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CannaTrac® Technology, Inc. (“CannaTrac®” or “the Company”), the leading cashless payment solution for the cannabis industry, today announced that it has come to an agreement with Pacific Banking Corp (“PBC”). CannaTrac® will provide state-licensed cannabis dispensaries and other retailers with the ability to apply for both the CannaCard® mobile payments platform and banking services with PBC simultaneously.
https://www.globenewswire.com/news-release/2019/09/05/1911486/0/en/CannaTrac-Announces-Agreement-with-Pacific-Banking-Corp-to-Offer-a-Universal-Application-for-CannaCard-Digital-Payments.html
GRN Funds - GRN Holding
https://www.directcannabisnetwork.com/holding-companies-cannabis-space-matter/
Even though Green Surprise Corp. now owns all of these companies, each respective business is still run out of its original headquarters and is managed by its original owners. Neither the companies nor their owners, have any interaction with one another and each company continues to maintain its original bank accounts and business operations.
Furthermore, Jeremy and Bobby make the very wise decision to keep each of these companies as autonomously registered LLCs with Green Surprise Corp becoming the owner and managing member of them all. Simply, these companies are now subsidiaries of the Green Surprise Corp., the holding company.
Role Summary For the Job Mr. Acuff Left to Come to PRED
Commercial Excellence Leader, Clinical Care Solutions
Role Summary:
The Commercial Excellence Leader, Clinical Care Solutions will lead efforts to drive efficient and effective coverage of targeted accounts LCS Account Managers, Product Sales Specialists, Inside Sales and Indirect Channels and in conjunction with Account Executives. This person will have a demonstrated track record of working with sales and service leadership, marketing, human resources and other functional areas to continually improve and distribution efficiency and effectiveness.
Essential Responsibilities:
Establish and drive key leading growth, relationship and commercial productivity indicators; drive execution on priorities to improve performance
Develop sales strategies aimed at improving sales productivity focused on outcome-selling, sales process standardization, tool adoption and sales metrics (pipeline, training, performance, etc).
Partner with key commercial and IT teams to drive implementation and adoption of the sales force technologies in support of account planning and sales force effectiveness priorities (includes CRM, iPad, other as indicated)
Partner with business functions by providing input to improve commercial field force hiring, performance management and talent planning practices.
Sets strategic plans that include organizational capability assessment and corresponding training & development and functional support plans in conjunction with Commercial business goals and objectives
Manage team to ensure alignment to organization strategies as well ability to execute specific initiatives within the organization, ensuring support across all sales force groups.
Responsible for assessment, recommendations and development of appropriate models (i.e. selling, coaching, Account Planning, Team Performance etc) to support efficient and effective field activities.
Responsible for management of the training process for needs assessment, design, and delivery through measurement controls to continuously improve training and development effectiveness
Partner with Marketing to drive coherent communication strategy to, with and through Account Executives
Qualifications/Requirements:
Bachelors Degree
5+ years experience in Sales/Services, Marketing, or Commercial Operation roles.
Demonstrated mastery of Account-based strategy development and Outcome-based selling
Ability to interface and influence at all levels in the organization
Demonstrated ability to lead and influence a cross functional team within a large, complex and matrixed organization
Proven track record on relationship building skills
Proficient in digital commercial tools, particularly Salesforce (CRM)
Excellent presentation, written and verbal communication skills
Desired Characteristics:
Advanced degree
Strong oral and written communication skills
Values: Clear thinker, Curious Learner, Leadership,
Demonstrated ability to excel in a fast-paced organization
#LI-KC1
About Us:
GE (NYSE:GE) drives the world forward by tackling its biggest challenges. By combining world-class engineering with software and analytics, GE helps the world work more efficiently, reliably, and safely. GE people are global, diverse and dedicated, operating with the highest integrity and passion to fulfill GEs mission and deliver for our customers. www.ge.com
GE offers a great work environment, professional development, challenging careers, and competitive compensation. GE is an Equal Opportunity Employer. Employment decisions are made without regard to race, color, religion, national or ethnic origin, gender (including pregnancy), sexual orientation, gender identity or expression, age, disability, veteran status or any other characteristics protected by law.
Additional Eligibility Qualifications:
GE will only employ those who are legally authorized to work in the United States for this opening. Any offer of employment is conditioned upon the successful completion of a drug screen (as applicable).
Additional Locations:
United States;Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Guam, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming;
https://www.glassdoor.com/job-listing/commercial-excellence-leader-clinical-care-solutions-ge-healthcare-JV_KO0,52_KE53,66.htm?jl=3257662320&ctt=1566594864225&srs=EI_JOBS
GRN Funds, LLC is Registered with The SEC as well
GRN Funds, LLC
SEC CIK #0001781434
SEC.report CIK GRN Funds, LLC
GRN Funds, LLC is registered with the U.S. Security and Exchange Commission. This page includes all SEC filing details as well as a list of any documents (S-1, Prospecuts, Current Reports, 8-K, 10K, Annual Reports) registered by GRN Funds, LLC.
https://sec.report/CIK/0001781434
PBC is the newest "Division" of GRN Funds as per the Shareholder letter. I would assume that means that PBC falls under the Registered Domain of GRN Funds, LLC
https://ccfs.sos.wa.gov/#/BusinessSearch/BusinessInformation
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 16, 2019
GRN HOLDING CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Nevada
(State or other jurisdiction of incorporation or organization)
Commission File Number
000-54709
27-2616571
(I.R.S. Employer
Identification Number)
1000 2nd Avenue, Suite 3900, Seattle, WA 98104
(Address of Principal Executive Offices and Zip Code)
(425) 830-1192
(Issuer's telephone number)
DISCOVERY GOLD CORPORATION
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Section 5 - Corporate Governance and Management
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
(a)(1) On July 16, 2019, the Board of Directors met and unanimously approved a resolution recommending an amendment to the Registrant’s articles of incorporation to change the name of the Registrant to GRN Holding Corporation, and to file a Corporate Action Notification Form with FINRA to formally change the Registrant’s name and trading symbol. The Board of Directors thereafter called for and convened a special meeting of the stockholders. On July 16, 2019, stockholders beneficially owning a majority of the shares eligible to vote consented to the amendment of the Registrant’s articles of incorporation to change its name to GRN Holding Corporation, and authorized the filing of a Corporate Action Notification Form with FINRA to formally change the Registrant’s name and trading symbol.
On August 19, 2019, the Registrant filed a formal amendment to its articles of incorporation with the Nevada Secretary of State formally changing its name to GRN Holding Corporation. Pursuant to 17 CFR 229.601(b)(3), the Registrant includes below a file stamped copy of its amended articles and business license.
The Registrant is proceeding with its application to FINRA for a name and symbol change, and will advise the Commission and the public for an expected market effective date for these changes in a press release and a disclosure on Form 8-K
Section 9 – Financial Statement and Exhibits
Item 9.01 Financial Statements and Exhibits
Exhibit Number Description
3.1 Certificate of Amendment
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated August 22, 2019
DISCOVERY GOLD CORPORATION
By: /s/ Justin Costello
Justin Costello
Chief Executive Officer
(Principal Executive Officer)